HIV-2 Vpx neutralizes host restriction factor SAMHD1 to promote viral pathogenesis

被引:8
|
作者
Mohamed, Ahlam [1 ]
Bakir, Talal [2 ]
Al-Hawel, Huda [1 ]
Al-Sharif, Ibtihaj [1 ]
Bakheet, Razan [1 ]
Kouser, Lubna [3 ]
Murugaiah, Valarmathy [4 ]
Al-Mozaini, Maha [1 ,2 ]
机构
[1] King Faisal Specialist Hosp & Res Ctr, Immunocompromised Host Res Sect, Dept Infect & Immun, POB 3354 MBC 03, Riyadh 11211, Saudi Arabia
[2] King Saud Univ, Coll Appl Med Sci, Dept Clin Labs Sci, Riyadh, Saudi Arabia
[3] Imperial Coll London, London, England
[4] Brunel Univ London, Biosci, Coll Hlth Med & Life Sci, London, England
关键词
AICARDI-GOUTIERES SYNDROME; TRIPHOSPHOHYDROLASE ACTIVITY; UBIQUITIN LIGASE; DNTP LEVELS; PROTEIN; TYPE-2; REPLICATION; DEGRADATION; MACROPHAGES; INHIBITION;
D O I
10.1038/s41598-021-00415-2
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
SAMHD1, a human host factor found in myeloid cells which restricts HIV-1 replication. It depletes the dNTPs pool for viral cDNA syntheses, thus preventing the viral replication in the cells. The viral accessory protein, Vpx, exists only in SIVmac/HIV-2 particles. Vpx in SIVmac can induce proteosomal degradation of SAMHD1, which then leads to a decrease in the cytoplasmic dNTP pool. The protein-protein interaction between Vpx and SAMHD1 and its consequences are still unclear. Methods: In this study, we cloned, for the first time, Vpx gene from a HIV-2 infected patient and found up to 30% sequence variation compared to known HIV-2 strains. We then analyzed the role of SAMHD1 protein expression in transfected THP-1 and U937 cells by transfecting with the Vpx gene derived from SIVmac, HIV-2 from the NIH sample as well as HIV-2 from a Saudi patient. We found that Vpx gene expression led to reduced levels of intracellular SAMHD1. When the supernatants of the transfected cell lines were examined for secreted cytokines, chemokines and growth factors, Vpx expression seemed to be suppressive of pro-inflammatory response, and skewed the immune response towards an anti-inflammatory response. These results suggest that Vpx can act at two levels: clearance of intracellular restriction factor and suppression of cytokine storm: both aimed at long-term latency and host-pathogen stand-off, suggesting that Vpx is likely to be a potential therapeutic target.
引用
收藏
页数:21
相关论文
共 50 条
  • [31] The efficiency of Vpx-mediated SAMHD1 antagonism does not correlate with the potency of viral control in HIV-2-infected individuals
    Hangxing Yu
    Shariq M Usmani
    Alexandra Borch
    Julia Krämer
    Christina M Stürzel
    Mohammad Khalid
    Xuehua Li
    Daniela Krnavek
    Marchina E van der Ende
    Albert D Osterhaus
    Rob A Gruters
    Frank Kirchhoff
    Retrovirology, 10
  • [32] The ribonuclease activity of SAMHD1 is required for HIV-1 restriction
    Ryoo, Jeongmin
    Choi, Jongsu
    Oh, Changhoon
    Kim, Sungchul
    Seo, Minji
    Kim, Seok-Young
    Seo, Daekwan
    Kim, Jongkyu
    White, Tommy E.
    Brandariz-Nunez, Alberto
    Diaz-Griffero, Felipe
    Yun, Cheol-Heui
    Hollenbaugh, Joseph A.
    Kim, Baek
    Baek, Daehyun
    Ahn, Kwangseog
    NATURE MEDICINE, 2014, 20 (08) : 936 - 941
  • [33] Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein
    Kasia Hrecka
    Caili Hao
    Magda Gierszewska
    Selene K. Swanson
    Malgorzata Kesik-Brodacka
    Smita Srivastava
    Laurence Florens
    Michael P. Washburn
    Jacek Skowronski
    Nature, 2011, 474 : 658 - 661
  • [34] PIM kinases facilitate lentiviral evasion from SAMHD1 restriction via Vpx phosphorylation
    Kei Miyakawa
    Satoko Matsunaga
    Masaru Yokoyama
    Masako Nomaguchi
    Yayoi Kimura
    Mayuko Nishi
    Hirokazu Kimura
    Hironori Sato
    Hisashi Hirano
    Tomohiko Tamura
    Hirofumi Akari
    Tomoyuki Miura
    Akio Adachi
    Tatsuya Sawasaki
    Naoki Yamamoto
    Akihide Ryo
    Nature Communications, 10
  • [35] PIM kinases facilitate lentiviral evasion from SAMHD1 restriction via Vpx phosphorylation
    Miyakawa, Kei
    Matsunaga, Satoko
    Yokoyama, Masaru
    Nomaguchi, Masako
    Kimura, Yayoi
    Nishi, Mayuko
    Kimura, Hirokazu
    Sato, Hironori
    Hirano, Hisashi
    Tamura, Tomohiko
    Akari, Hirofumi
    Miura, Tomoyuki
    Adachi, Akio
    Sawasaki, Tatsuya
    Yamamoto, Naoki
    Ryo, Akihide
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [36] Intertwined: SAMHD1 cellular functions, restriction, and viral evasion strategies
    Majer, Catharina
    Schuessler, Jan Moritz
    Koenig, Renate
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2019, 208 (3-4) : 513 - 529
  • [37] The efficiency of Vpx-mediated SAMHD1 antagonism does not correlate with the potency of viral control in HIV-2-infected individuals
    Yu, Hangxing
    Usmani, Shariq M.
    Borch, Alexandra
    Kraemer, Julia
    Stuerzel, Christina M.
    Khalid, Mohammad
    Li, Xuehua
    Krnavek, Daniela
    van der Ende, Marchina E.
    Osterhaus, Albert D.
    Gruters, Rob A.
    Kirchhoff, Frank
    RETROVIROLOGY, 2013, 10
  • [38] The ribonuclease activity of SAMHD1 is required for HIV-1 restriction
    Jeongmin Ryoo
    Jongsu Choi
    Changhoon Oh
    Sungchul Kim
    Minji Seo
    Seok-Young Kim
    Daekwan Seo
    Jongkyu Kim
    Tommy E White
    Alberto Brandariz-Nuñez
    Felipe Diaz-Griffero
    Cheol-Heui Yun
    Joseph A Hollenbaugh
    Baek Kim
    Daehyun Baek
    Kwangseog Ahn
    Nature Medicine, 2014, 20 : 936 - 941
  • [39] Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein
    Hrecka, Kasia
    Hao, Caili
    Gierszewska, Magda
    Swanson, Selene K.
    Kesik-Brodacka, Malgorzata
    Srivastava, Smita
    Florens, Laurence
    Washburn, Michael P.
    Skowronski, Jacek
    NATURE, 2011, 474 (7353) : 658 - U137
  • [40] Intertwined: SAMHD1 cellular functions, restriction, and viral evasion strategies
    Catharina Majer
    Jan Moritz Schüssler
    Renate König
    Medical Microbiology and Immunology, 2019, 208 : 513 - 529